Publication | Open Access
Prefluostatin and New Urauchimycin Derivatives Produced by Streptomycete Isolates
23
Citations
0
References
2006
Year
Antibiotic AdjuvantEscherichia ColiAntimicrobial ChemotherapyDrug ResistanceBiosynthesisNatural Product BiosynthesisUrauchimycin CAntibacterial MechanismsAntimicrobial ResistanceHealth SciencesAntimicrobial Drug DiscoveryAntibacterial AgentAntimicrobial PharmacokineticsAntimicrobial CompoundFood PreservativesPharmacologyStreptomycete IsolatesAntimycin GroupAntimicrobial SusceptibilityAntibioticsMicrobiologyAntimicrobial PharmacodynamicsMedicine
Abstract Guided by chemical screening, two new members of the antimycin group, urauchimycin C (1b) and D (1a), were isolated from the marine-derived Streptomyces sp. isolate B1751 and from a terrestrial strain AdM21, together with prefluostatin (2), a new natural derivative of isoprekinamycin (4). Their structures were established on the basis of NMR data and by comparison with known compounds. In the agar diffusion test, urauchimycin C (1b) and D (1a) were antibiotically inactive against some bacteria and fungi at a concentration of 25 μg per paper disk, while the isoprekinamycin derivative 2 showed weak cytotoxicity and moderate activity in the agar diffusion test against Bacillus subtilis, Mucor miehei, Escherichia coli and Staphylococcus aureus at concentrations of 20 μg per paper disk.